Appointment of Kelsey Ramsden as CEO adds a seasoned executive with a track record of innovation and company development.
January 18, 2023 – New Brunswick, New Jersey – Atelier Meats Corp. (“Atelier Meats” or the “Company”), a biotechnology company focused on development and commercialization of cultivated meats, is pleased to announce the appointment of Kelsey Ramsden as Chief Executive Officer. Ms. Ramsden will lead the Company’s executive team with a focus on further developing the Company’s scientific, strategic and development initiatives.
Kelsey possesses over 20 years of experience founding, scaling and operating innovative companies across Canada and the Caribbean. She has built multiple 8-figure businesses from the ground up and has twice been named Canada’s Top Female Entrepreneur. Kelsey is also an accomplished keynote speaker, university professor and published author.
Kelsey holds an MBA from the Richard Ivey School of Business at the University of Western Ontario.
Dr. Mohit Bhatia, co-founder and CSO states, “We are very pleased to have an accomplished company builder such as Kelsey join our executive team. In the past year, the Company has achieved several key operational, scientific and strategic accomplishments. Kelsey’s appointment is another step and key piece in our executing strategy to add accomplished leaders, accelerating further growth in the Company. She has a demonstrated track record of senior leadership skills, capital markets experience, as well as scaling and building companies, and we are excited by her commitment to further the Company’s key strategic priorities.”
“I believe that the most exciting organizations to lead and opportunities to be had are those where the cutting edge of technology meets the leading edge of market and cultural change. Atelier Meats IP strategy and world class scientific team positions us squarely at that imperative intersection. As global meat supply demands a revolutionary inflection point, consumer and regulatory changes are aligning to rapidly accelerate the opportunities in the cultivated meat market. I am honored to be on this team at this moment of tremendous opportunity.”
Ms. Ramsden replaces Leighton Bocking in the role of CEO and the Company would like to thank Mr. Leighton Bocking for his contributions to the executive team to date. Mr. Bocking will remain as a member of the Company’s board of directors.
Atelier Meats is committed to creating delicious, healthy and environmentally conscious protein sources for the world, without killing a single animal. The Company believes it has built a solid foundation and strategy that incorporates strong partnerships with recognized industry leaders, a world-class team, a growing intellectual property portfolio, all supported by a solid capital markets strategy to propel future growth.
About Atelier Meats Corp.
Atelier is a biotechnology company dedicated to developing quality, cultivated meats. Led by a world-class team, with proprietary patent-pending technology, Atelier’s mission is to produce healthier and environmentally conscious proteins for the world - without harming a single animal in the process.
For further information please contact:
Atelier Meats Corp.
To download this press release, click here.
Forward Looking Disclaimer
This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements and information can be identified by the use of words such as “plans”, “expects”, “intends”, “is expected”, “potential”, “suggests” or variations of such words or phrases, or statements that certain actions, events or results “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, statements regarding expectations of management regarding: further developing the Company’s operational, strategic and development initiatives; and creating a healthier and environmentally conscious protein source for the world. Accordingly, forward-looking statements in this news release reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. The novel strain of coronavirus, COVID-19 and risk of future pandemics, also continues to pose risks that are currently indescribable and immeasurable. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The reader is cautioned not to place undue reliance on any forward-looking statements. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.